Medical Condition | Idiopathic Pulmonary Fibrosis |
Facility/Clinic | Accellacare – 1222 Medical Center Dr |
Age | 40+ |
Gender | Male & Female |
Description | A study to measure the safety and efficacy of two different dosages of study medication versus placebo to treat Idiopathic Pulmonary Fibrosis. |
Enrollment | Open |
Patient Commitment Duration | minimum of 14 months – up to 4 years |
Number of visits in study | 14+ visits |
Patient Compensation | $100/visit |
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-799-5500 between the hours of 8am-5pm for general research questions.